GlassScriptPhysician profile
Farhan M Bhatti
NPI 1326308057
$229,703.01
in general payments reported to CMS, 2019-2025
43 companies · $16K in 2025
The $16K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41K · 2020: $45K · 2021: $36K · 2022: $40K · 2023: $38K · 2024: $15K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $58K · Food and Beverage: $5,187 · Travel and Lodging: $3,165 · Consulting Fee: $2,013 · Education: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $58,062.50 |
| Food and Beverage | $5,186.79 |
| Travel and Lodging | $3,165.28 |
| Consulting Fee | $2,012.50 |
| Education | $242.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $133,545.60 | 2021-2025 | Vraylar, Mavyret, Ubrelvy |
| Allergan, INC. | $88,937.74 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $748.86 | 2020-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $664.75 | 2019-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Teva Pharmaceuticals USA, INC. | $615.93 | 2020-2025 | Austedo Xr, Austedo Xr, Uzedy |
| Alkermes, INC. | $479.83 | 2019-2025 | Aristada, Lybalvi, Vivitrol |
| Neurocrine Biosciences, INC. | $408.69 | 2019-2025 | Ingrezza |
| Pfizer INC. | $372.43 | 2019-2025 | |
| Glaxosmithkline, LLC. | $368.67 | 2020-2025 | Trelegy Ellipta, Arexvy |
| Supernus Pharmaceuticals, INC. | $315.32 | 2019-2025 | Qelbree |
| Lundbeck LLC | $301.75 | 2020-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $285.69 | 2019-2025 | Jardiance, Ofev |
| Novo Nordisk INC | $282.46 | 2020-2025 | Ozempic, Wegovy |
| Janssen Pharmaceuticals, INC | $243.34 | 2020-2025 | Spravato, Invega Sustenna |
| Lilly USA, LLC | $240.13 | 2020-2025 | Mounjaro, Zepbound |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $239.70 | 2019-2025 | Fanapt |
| Gilead Sciences, INC. | $176.51 | 2020-2025 | |
| Exact Sciences Corporation | $168.18 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sunovion Pharmaceuticals INC. | $123.75 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $99.90 | 2020-2022 | |
| Ironshore Pharmaceuticals INC. | $88.57 | 2022-2024 | Jornay Pm |
| Amgen INC. | $86.16 | 2020-2023 | Repatha, Otezla |
| Abbott Laboratories | $84.14 | 2024-2025 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $82.98 | 2019-2024 | Capvaxive, Gardasil, Gardasil 9 |
| E.R. Squibb & Sons, L.L.C. | $73.22 | 2025 | Cobenfy |
| Mylan Specialty L.P. | $69.46 | 2022-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $63.86 | 2021-2023 | Trintellix |
| Averitas Pharma INC. | $61.48 | 2023-2024 | Qutenza |
| Astrazeneca Pharmaceuticals LP | $58.34 | 2020-2024 | Fasenra, Airsupra |
| Phathom Pharmaceuticals, INC. | $57.08 | 2024-2025 | Voquezna |
| Axsome Therapeutics, INC. | $45.83 | 2024-2025 | Auvelity |
| Corium, LLC | $45.71 | 2024-2025 | Azstarys |
| Scilex Pharmaceuticals INC. | $44.79 | 2024 | |
| Antares Pharma, INC. | $36.73 | 2022-2025 | Xyosted |
| Nestle Healthcare Nutrition INC. | $29.83 | 2022 | |
| Grt US Holding, INC. | $22.80 | 2022 | |
| Rgh Enterprises LLC | $22.00 | 2025 | |
| Alnylam Pharmaceuticals INC. | $21.68 | 2025 | Givlaari |
| Seqirus USA INC | $21.07 | 2025 | Flucelvax |
| Biohaven Pharmaceutical Holding Company LTD. | $20.66 | 2022 | |
| Global Blood Therapeutics, INC. | $17.31 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.99 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farhan Bhatti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.